Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2017 1
2018 1
2019 1
2020 3
2021 3
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Innovations in medical therapy of heart failure with reduced ejection fraction.
Mercurio V, Ambrosio G, Correale M, Dini FL, Ghio S, Nodari S, Palazzuoli A, Ruocco G, Pedrinelli R, Mercuro G, Filardi PP, Indolfi C, Agostoni P, Tocchetti CG, Paolillo S. Mercurio V, et al. J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e47-e54. doi: 10.2459/JCM.0000000000001413. Epub 2022 Dec 15. J Cardiovasc Med (Hagerstown). 2023. PMID: 36729606 Review.
Asymptomatic infection with clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) in carnivore pets, Italy, April 2023.
Moreno A, Bonfante F, Bortolami A, Cassaniti I, Caruana A, Cottini V, Cereda D, Farioli M, Fusaro A, Lavazza A, Lecchini P, Lelli D, Maroni Ponti A, Nassuato C, Pastori A, Rovida F, Ruocco L, Sordilli M, Baldanti F, Terregino C. Moreno A, et al. Euro Surveill. 2023 Aug;28(35):2300441. doi: 10.2807/1560-7917.ES.2023.28.35.2300441. Euro Surveill. 2023. PMID: 37650905 Free PMC article.
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
HPS3/TIMI55–REVEAL Collaborative Group; Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ. HPS3/TIMI55–REVEAL Collaborative Group, et al. N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28. N Engl J Med. 2017. PMID: 28847206 Free article. Clinical Trial.
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes.
Palazzuoli A, Caravita S, Paolillo S, Ghio S, Tocchetti CG, Ruocco G, Correale M, Ambrosio G, Perrone Filardi P, Senni M; Italian Society of Cardiology Heart Failure Study Group. Palazzuoli A, et al. Prog Cardiovasc Dis. 2021 Jul-Aug;67:89-97. doi: 10.1016/j.pcad.2021.03.007. Epub 2021 Apr 9. Prog Cardiovasc Dis. 2021. PMID: 33839166 Review.
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside.
Sardu C, Massetti M, Scisciola L, Trotta MC, Santamaria M, Volpicelli M, Ducceschi V, Signoriello G, D'Onofrio N, Marfella L, Casolaro F, Amico MD', Ruocco A, Balestrieri ML, Mauro C, Rafaniello C, Capuano A, Paolisso G, Marfella R. Sardu C, et al. Pharmacol Res. 2022 Aug;182:106303. doi: 10.1016/j.phrs.2022.106303. Epub 2022 Jun 10. Pharmacol Res. 2022. PMID: 35697289 Free article.
Correction to: Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
Russo V, Caturano A, Guerra F, Migliore F, Mascia G, Rossi A, Nesti M, Santobuono VE, Attena E, Tola G, Sciarra L, Conte G, Paoletti Perini A, Francia P, Dendramis G, Palamà Z, Albani S, Ottonelli Ghidini A, Calò L, D'Onofrio A, Baldi E; IBRYD Study Group. Russo V, et al. Heart Vessels. 2023 May;38(5):689-690. doi: 10.1007/s00380-022-02228-3. Heart Vessels. 2023. PMID: 36607387 Free PMC article. No abstract available.
15 results